Primary Outcome Measures:
- For each dialyzer, the perceived ease of priming. [ Time Frame: During priming of each dialyzer ] [ Designated as safety issue: No ]
Secondary Outcome Measures:
- Visual assessment of residual blood in the dialyzer after rinse-back and if dialyzer clotted during treatment. [ Time Frame: At the completion of each treatment ] [ Designated as safety issue: No ]
Device: Gambro HD-C4 Small Dialyzer
Involves the use of FDA 510(k) cleared hemodialyzers and will have no impact on the patient's routine dialysis therapy.
Market evaluation protocol.
This ease of use study involves the use of FDA 510(k) cleared hemodialyzers and will have no impact on the patient's routine dialysis therapy. This study is strictly aimed at obtaining feedback from the nursing and technical staff regarding the use of the Polyflux HD-C4 Small dialyzer. The dialysis nursing staff will complete ease of use assessments following routine dialysis therapy.